Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of the American Chemical Society|October 3, 2023
An Asymmetric Aromatic Finkelstein Reaction: A Platform for Remote Diarylmethane DesymmetrizationTobias Morack, Tyler E Myers, Lucas J Karas, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2004
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II studyP Schmid, J Krocker, G Morack, et al.
Nature Chemistry|July 17, 2025
Energy transfer-enabled enantioselective photocyclization using a privileged Al-salen catalystJulia Soika, Carina Onneken, Thorben Wiegmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II studyT Bauknecht, A Hefti, G Morack, et al.
Women'S Health Reports (New Rochelle, N.Y.)|May 1, 2025
High and Rapid Uptake of COVID-19 Vaccine Among Chicago Women with and Without HIVElizabeth Daubert, Mardge H Cohen, Tsion Yohannes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trialJ-U Blohmer, P Schmid, J Hilfrich, et al.
Brain and Behavior|August 7, 2023
Overnight urinary melatonin levels in women with and without HIV: An observational cohort studyHelen J Burgess, Kathleen M Weber, Ralph Morack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2005
First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III studyO Feher, P Vodvarka, J Jassem, et al.
Pageof 6